Search Results

There are 6187 results for: content related to: The role of genetic markers in hepatitis C virus therapy: a major step for individualized care

  1. You have free access to this content
    Role of IL28B for chronic hepatitis C treatment toward personalized medicine

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue 2, February 2014, Pages: 241–249, Kentaro Matsuura, Tsunamasa Watanabe and Yasuhito Tanaka

    Version of Record online : 27 JAN 2014, DOI: 10.1111/jgh.12475

  2. You have free access to this content
    Host genomics and HCV treatment response

    Journal of Gastroenterology and Hepatology

    Volume 27, Issue 2, February 2012, Pages: 212–222, Paul J Clark and Alexander J Thompson

    Version of Record online : 20 JAN 2012, DOI: 10.1111/j.1440-1746.2011.06918.x

  3. You have free access to this content
    Association of gene expression involving innate immunity and genetic variation in interleukin 28B with antiviral response

    Hepatology

    Volume 55, Issue 1, January 2012, Pages: 20–29, Yasuhiro Asahina, Kaoru Tsuchiya, Masaru Muraoka, Keisuke Tanaka, Yuichiro Suzuki, Nobuharu Tamaki, Yoshihide Hoshioka, Yutaka Yasui, Tomoji Katoh, Takanori Hosokawa, Ken Ueda, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Masayuki Kurosaki, Nobuyuki Enomoto, Sayuri Nitta, Naoya Sakamoto and Namiki Izumi

    Version of Record online : 29 NOV 2011, DOI: 10.1002/hep.24623

  4. Impaired induction of interleukin 28B and expression of interferon λ 4 associated with nonresponse to interferon-based therapy in chronic hepatitis C

    Journal of Gastroenterology and Hepatology

    Volume 30, Issue 6, June 2015, Pages: 1075–1084, Miyako Murakawa, Yasuhiro Asahina, Mina Nakagawa, Naoya Sakamoto, Sayuri Nitta, Akiko Kusano-Kitazume, Takako Watanabe, Fukiko Kawai-Kitahata, Satoshi Otani, Miki Taniguchi, Fumio Goto, Yuki Nishimura-Sakurai, Yasuhiro Itsui, Seishin Azuma, Sei Kakinuma and Mamoru Watanabe

    Version of Record online : 27 APR 2015, DOI: 10.1111/jgh.12902

  5. You have free access to this content
    Limited use of interleukin 28B in the setting of response-guided treatment with detailed on-treatment virological monitoring

    Hepatology

    Volume 54, Issue 3, 2 September 2011, Pages: 772–780, Alessandra Mangia, Alexander J. Thompson, Rosanna Santoro, Valeria Piazzolla, Massimiliano Copetti, Nicola Minerva, Daniela Petruzzellis, Leonardo Mottola, Donato Bacca and John G. McHutchison

    Version of Record online : 21 JUL 2011, DOI: 10.1002/hep.24458

  6. You have free access to this content
    IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C

    Hepatology

    Volume 52, Issue 6, December 2010, Pages: 1888–1896, Thomas J. Urban, Alexander J. Thompson, Shelton S. Bradrick, Jacques Fellay, Detlef Schuppan, Kenneth D. Cronin, Linda Hong, Alexander McKenzie, Keyur Patel, Kevin V. Shianna, John G. McHutchison, David B. Goldstein and Nezam Afdhal

    Version of Record online : 7 OCT 2010, DOI: 10.1002/hep.23912

  7. You have free access to this content
    Hepatitis C pharmacogenetics: State of the art in 2010

    Hepatology

    Volume 53, Issue 1, January 2011, Pages: 336–345, Nezam H. Afdhal, John G. McHutchison, Stefan Zeuzem, Alessandra Mangia, Jean-Michel Pawlotsky, Jeffrey S. Murray, Kevin V. Shianna, Yasuhito Tanaka, David L. Thomas, David R. Booth, David B. Goldstein and for the Pharmacogenetics and Hepatitis C Meeting Participants

    Version of Record online : 12 JAN 2011, DOI: 10.1002/hep.24052

  8. The Role of Pharmacogenetics in the Treatment of Chronic Hepatitis C Infection

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 34, Issue 2, February 2014, Pages: 185–201, Marina Kawaguchi-Suzuki and Reginald F. Frye

    Version of Record online : 30 SEP 2013, DOI: 10.1002/phar.1349

  9. You have free access to this content
    Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection

    Hepatology

    Volume 53, Issue 1, January 2011, Pages: 317–324, Michael R. Charlton, Alexander Thompson, Bart J. Veldt, Kym Watt, Hans Tillmann, John J. Poterucha, Julie K. Heimbach, David Goldstein and John McHutchison

    Version of Record online : 12 JAN 2011, DOI: 10.1002/hep.24074

  10. Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response

    Journal of Viral Hepatitis

    Volume 19, Issue 5, May 2012, Pages: 332–340, P. J. Clark, A. J. Thompson, M. Zhu, D. M. Vock, Q. Zhu, D. Ge, K. Patel, S. A. Harrison, T. J. Urban, S. Naggie, J. Fellay, H. L. Tillmann, K. Shianna, S. Noviello, L. D. Pedicone, R. Esteban, P. Kwo, M. S. Sulkowski, N. Afdhal, J. K. Albrecht, D. B. Goldstein, J. G. McHutchison, A. J. Muir and for the IDEAL investigators

    Version of Record online : 22 FEB 2012, DOI: 10.1111/j.1365-2893.2011.01553.x

  11. You have free access to this content
    Introduction to the genetics and biology of interleukin-28B

    Hepatology

    Volume 56, Issue 1, July 2012, Pages: 361–366, Thomas Urban, Michael R. Charlton and David B. Goldstein

    Version of Record online : 3 JUL 2012, DOI: 10.1002/hep.25794

  12. You have free access to this content
    Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B-unfavorable genotype patients: Impaired viral kinetics and therapeutic response

    Hepatology

    Volume 56, Issue 2, August 2012, Pages: 444–454, Susanna Naggie, Anu Osinusi, Antonios Katsounas, Richard Lempicki, Eva Herrmann, Alexander J. Thompson, Paul J. Clark, Keyur Patel, Andrew J. Muir, John G. McHutchison, Joerg F. Schlaak, Martin Trippler, Bhavana Shivakumar, Henry Masur, Michael A. Polis and Shyam Kottilil

    Version of Record online : 2 JUL 2012, DOI: 10.1002/hep.25647

  13. Genetic variant of IL28B rs12979860, as predictive marker of interferon-based therapy in Pakistani population

    APMIS

    Volume 123, Issue 4, April 2015, Pages: 342–349, Muhammad Imran, Sobia Manzoor, Sikandar Azam and Saleha Resham

    Version of Record online : 20 FEB 2015, DOI: 10.1111/apm.12365

  14. You have free access to this content
    Recipient IL28B Polymorphism Is an Important Independent Predictor of Posttransplant Diabetes Mellitus in Liver Transplant Patients with Chronic Hepatitis C

    American Journal of Transplantation

    Volume 12, Issue 3, March 2012, Pages: 737–744, B. J. Veldt, A. Duarte-Rojo, A. J. Thompson, K. D. Watt, J. K. Heimbach, H. L. Tillmann, D. D. Goldstein, J. G. McHutchison and M. R. Charlton

    Version of Record online : 2 FEB 2012, DOI: 10.1111/j.1600-6143.2011.03843.x

  15. Serum interferon-gamma-inducible protein-10 concentrations and IL28B genotype associated with responses to pegylated interferon plus ribavirin with and without telaprevir for chronic hepatitis C

    Hepatology Research

    Volume 44, Issue 12, November 2014, Pages: 1208–1216, Kentaro Matsuura, Tsunamasa Watanabe, Sayuki Iijima, Shuko Murakami, Kei Fujiwara, Etsuro Orito, Etsuko Iio, Mio Endo, Atsunori Kusakabe, Noboru Shinkai, Tomokatsu Miyaki, Shunsuke Nojiri, Takashi Joh and Yasuhito Tanaka

    Version of Record online : 17 FEB 2014, DOI: 10.1111/hepr.12294

  16. IL28RA polymorphism is associated with early hepatitis C virus (HCV) treatment failure in human immunodeficiency virus-/HCV-coinfected patients

    Journal of Viral Hepatitis

    Volume 20, Issue 5, May 2013, Pages: 358–366, M. A. Jiménez-Sousa, J. Berenguer, N. Rallón, M. Guzmán-Fulgencio, J. C. López, V. Soriano, A. Fernández-Rodríguez, J. Cosín, C. Restrepo, M. García-Álvarez, P. Miralles, J. M. Benito and S. Resino

    Version of Record online : 20 DEC 2012, DOI: 10.1111/jvh.12041

  17. You have free access to this content
    IL28B genetic polymorphism testing in the era of direct acting antivirals therapy for chronic hepatitis C: ten years too late?

    Liver International

    Volume 32, Issue s1, February 2012, Pages: 74–78, Donald M. Jensen and Stanislas Pol

    Version of Record online : 29 DEC 2011, DOI: 10.1111/j.1478-3231.2011.02712.x

  18. Interleukin-28B single nucleotide polymorphism of donors and recipients can predict viral response to pegylated interferon/ribavirin therapy in patients with recurrent hepatitis C after living donor liver transplantation

    Journal of Gastroenterology and Hepatology

    Volume 27, Issue 9, September 2012, Pages: 1467–1472, Tomokazu Kawaoka, Shoichi Takahashi, Shintaro Takaki, Akira Hiramatsu, Koji Waki, Nobuhiko Hiraga, Daiki Miki, Masataka Tsuge, Michio Imamura, Yoshiiku Kawakami, Hiroshi Aikata, Hidenori Ochi, Takashi Onoe, Hirotaka Tashiro, Hideki Ohdan and Kazuaki Chayama

    Version of Record online : 21 AUG 2012, DOI: 10.1111/j.1440-1746.2012.07129.x

  19. Association of IL28B polymorphisms with virological response to peginterferon and ribavirin therapy in children and adolescents with chronic hepatitis C

    Hepatology Research

    Volume 44, Issue 10, October 2014, Pages: E38–E44, Hitoshi Tajiri, Yasuhito Tanaka, Tomoko Takano, Mitsuyoshi Suzuki, Daiki Abukawa, Yoko Miyoshi, Toshiaki Shimizu and Stephen Brooks

    Version of Record online : 7 JAN 2014, DOI: 10.1111/hepr.12206

  20. Value of interleukin-28B genetic polymorphism on retreatment outcomes of chronic hepatitis C genotype 1 relapsers by peginterferon alfa plus ribavirin

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue 1, January 2014, Pages: 102–109, Ming-Yao Chen, Chen-Hua Liu, Ting-Chih Chen, Tung-Hung Su, Pei-Jer Chen, Ding-Shinn Chen, Jia-Horng Kao and Chun-Jen Liu

    Version of Record online : 19 DEC 2013, DOI: 10.1111/jgh.12329